Guglielmi A - Search Results

1

Determinants of sensitivity and resistance to fluoropyrimidines.

Aschele C, Guglielmi A, Maioli D, Sobrero A, Rosso R, Nicolin A. Aschele C, et al. Among authors: guglielmi a. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:1-2. doi: 10.1016/s1043-6618(09)80001-7. Pharmacol Res. 1990. PMID: 2151469 No abstract available.

2

[Cell resistance in oncology. Therapeutic prospects].

Rosso R, Guglielmi A, Aschele C, Mori A, Tixi L, Bolli E, Sobrero A. Rosso R, et al. Among authors: guglielmi a. G Ital Chemioter. 1991 Jan-Dec;38(1-3):95-7. G Ital Chemioter. 1991. PMID: 1365622 Italian. No abstract available.

3

Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.

Sobrero A, Aschele C, Guglielmi A, Nobile MT, Rosso R. Sobrero A, et al. Among authors: guglielmi a. J Chemother. 1990 Feb;2 Suppl 1:12-6. doi: 10.1080/1120009x.1990.11738999. J Chemother. 1990. PMID: 2142213

4

Standard indication of immunotherapy for the treatment of cancer.

Bolli E, Tixi L, Mori A, Guglielmi A, Aschele C, Rovini E, Sobrero A. Bolli E, et al. Among authors: guglielmi a. Pharmacol Res. 1992 Sep;26 Suppl 2:100-1. doi: 10.1016/1043-6618(92)90617-k. Pharmacol Res. 1992. PMID: 1384019 No abstract available.

5

Current strategies to reduce cisplatin toxicity.

Sobrero A, Guglielmi A, Aschele C, Rosso R. Sobrero A, et al. Among authors: guglielmi a. J Chemother. 1990 Feb;2(1):3-7. doi: 10.1080/1120009x.1990.11738971. J Chemother. 1990. PMID: 2185345 Review. No abstract available.

6

5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas).

Bolli E, Saccomanno S, Mondini G, Aschele C, Guglielmi A, Ligas B, Connio M, Mori A, Rosso R, Sobrero A, et al. Bolli E, et al. Among authors: guglielmi a. Cancer Chemother Pharmacol. 1995;35(4):339-42. doi: 10.1007/BF00689455. Cancer Chemother Pharmacol. 1995. PMID: 7828278 Clinical Trial.

7

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil.

Mori A, Bertoglio S, Guglielmi A, Aschele C, Bolli E, Tixi L, Rosso R, Sobrero A. Mori A, et al. Among authors: guglielmi a. Cancer Chemother Pharmacol. 1993;33(2):179-80. doi: 10.1007/BF00685339. Cancer Chemother Pharmacol. 1993. PMID: 8261580

8

Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.

Guglielmi A, Aschele C, Grossi F, Tixi L, Sobrero A. Guglielmi A, et al. Cytotechnology. 1996;19(3):215-9. doi: 10.1007/BF00744215. Cytotechnology. 1996. PMID: 8862009 Clinical Trial.

9

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study.

Aschele C, Guglielmi A, Frassineti GL, Milandri C, Amadori D, Labianca R, Vinci M, Tixi L, Caroti C, Ciferri E, Verdi E, Rosso R, Sobrero A. Aschele C, et al. Among authors: guglielmi a. Br J Cancer. 1998;77(2):341-6. doi: 10.1038/bjc.1998.53. Br J Cancer. 1998. PMID: 9461008 Free PMC article. Clinical Trial.

10

In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.

Guglielmi A, Aschele C, Mori A, Baldo C, Russo P, Debernardis D, Valenti M, Bruno S, Taverna M, Rosso R, et al. Guglielmi A, et al. Clin Cancer Res. 1995 Nov;1(11):1337-44. Clin Cancer Res. 1995. PMID: 9815929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters